{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:01:12Z","timestamp":1792522872305,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jad.2012.02.031","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T01:30:43Z","timestamp":1331256643000},"page":"S15-S21","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S","title":["Aripiprazole in pediatric psychosis and bipolar disorder: A clinical review"],"prefix":"10.1016","volume":"138","author":[{"given":"Tamison","family":"Doey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2012.02.031_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0193-953X(18)30987-0","article-title":"Psychotic forms of depression and mania","volume":"2","author":"Akiskal","year":"1979","journal-title":"The Psychiatric Clinics of North America"},{"key":"10.1016\/j.jad.2012.02.031_bb0005","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archpsyc.1985.01790330076009","article-title":"Affective disorders in referred children and younger siblings of manic-depressives. Mode of onset and prospective course","volume":"42","author":"Akiskal","year":"1985","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2012.02.031_bb0015","first-page":"45","article-title":"Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials","volume":"43","author":"Ardizzone","year":"2010","journal-title":"Psychopharmacology Bulletin"},{"issue":"6","key":"10.1016\/j.jad.2012.02.031_bb0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/JCP.0b013e31815a582a","article-title":"Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in an adolescent","volume":"27","author":"Bachmann","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jad.2012.02.031_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0029-1202266","article-title":"Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review","volume":"42","author":"Bachmann","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.jad.2012.02.031_bb0030","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/cap.2004.14.593","article-title":"The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review","volume":"14","author":"Barzman","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2012.02.031_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S1092852900019489","article-title":"Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review","volume":"10","author":"Biederman","year":"2005","journal-title":"CNS Spectrums"},{"issue":"9","key":"10.1016\/j.jad.2012.02.031_bb0040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1017\/S1092852900021519","article-title":"An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder","volume":"12","author":"Biederman","year":"2007","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.jad.2012.02.031_bb0045","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/jcp.0b013e31815ac4e5","article-title":"Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives","volume":"27","author":"Byerly","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.02.031_bb0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0327(88)90019-5","article-title":"Manic symptoms in a non-referred adolescent population","volume":"15","author":"Carlson","year":"1988","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.02.031_bb0055","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.schres.2007.12.089","article-title":"Acute efficacy of aripiprazole for the treatment of bipolar I disorder in pediatric patients","volume":"98","author":"Carson","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1016\/j.jad.2012.02.031_bb0060","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4088\/JCP.v69n0505","article-title":"Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial","volume":"69","author":"Chang","year":"2008","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.02.031_bb0065","first-page":"44","article-title":"Weight gain with atypical antipsychotics in children and adolescents: a meta-analysis","volume":"3","author":"Cohen","year":"2010"},{"issue":"10","key":"10.1016\/j.jad.2012.02.031_bb0070","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaac.2010.07.007","article-title":"National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996\u20132007","volume":"49","author":"Comer","year":"2010","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.jad.2012.02.031_bb0075","series-title":"AACAP 2010. Symposium Presentation 14.4","article-title":"Cardiometabolic risk modification in antipsychotic-treated youth with severe psychiatric disorders","author":"Correll","year":"2010"},{"issue":"2","key":"10.1016\/j.jad.2012.02.031_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","article-title":"Tardive dyskinesia and new antipsychotics","volume":"21","author":"Correll","year":"2008","journal-title":"Current Opinion in Psychiatry"},{"issue":"16","key":"10.1016\/j.jad.2012.02.031_bb0080","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA : The Journal of the American Medical Association"},{"issue":"20aa","key":"10.1016\/j.jad.2012.02.031_bb0090","article-title":"Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice","author":"De Hert","year":"2011","journal-title":"European Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.jad.2012.02.031_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2004.10.009","article-title":"High rate of unrecognized bipolar mixed states among destitute Hispanic adolescents referred for \u201cmajor depressive disorder\u201d","volume":"84","author":"Dilsaver","year":"2005","journal-title":"Journal of Affective Disorders"},{"issue":"10","key":"10.1016\/j.jad.2012.02.031_bb0100","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4088\/JCP.v64n1005","article-title":"Occult mood disorders in 104 consecutively presenting children referred for the treatment of attention deficit\/hyperactivity disorder in a community mental health clinic","volume":"64","author":"Dilsaver","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.02.031_bb0105","first-page":"43","article-title":"Quality of life improvement in adolescent schizophrenia and pediatric bipolar disorder following treatment with aripiprazole","volume":"6","author":"Endicott","year":"2009"},{"issue":"11","key":"10.1016\/j.jad.2012.02.031_bb0110","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.2008.07061035","article-title":"A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia","volume":"165","author":"Findling","year":"2008","journal-title":"The American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2012.02.031_bb0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/JCP.0b013e31817dd520","article-title":"Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study","volume":"28","author":"Findling","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"10","key":"10.1016\/j.jad.2012.02.031_bb0120","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.09m05164yel","article-title":"Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study","volume":"70","author":"Findling","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.02.031_bb0125","series-title":"Poster Presented at the XXVIth Collegium Internationale Neuropsychopharmacologium, Munich, Germany","article-title":"Long-term tolerability and safety of aripiprazole in pediatric patients with schizophrenia or bipolar I disorder","author":"Forbes","year":"2008"},{"issue":"8","key":"10.1016\/j.jad.2012.02.031_bb0130","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.euroneuro.2010.07.002","article-title":"Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons","volume":"21","author":"Fraguas","year":"2010","journal-title":"European Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.jad.2012.02.031_bb0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/cap.2009.0012","article-title":"Clozapine-aripiprazole association in a 7-year-old girl with schizophrenia: clinical efficacy and successful management of neutropenia with lithium","volume":"19","author":"Gagliano","year":"2009","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2012.02.031_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3371\/CSRP.5.2.3","article-title":"Changes in weight and other metabolic indicators in persons with schizophrenia following a switch to aripiprazole","volume":"5","author":"Ganguli","year":"2011","journal-title":"Clinical Schizophrenia & Related Psychoses"},{"issue":"9","key":"10.1016\/j.jad.2012.02.031_bb0145","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/00004583-199709000-00008","article-title":"Child and adolescent bipolar disorder: a review of the past 10 years","volume":"36","author":"Geller","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2012.02.031_bb0150","first-page":"271","article-title":"P01-270 \u2014 aripiprazole in adolescents with intellectual disabilities and schizophrenia: a case report","volume":"26","author":"Giannakopoulos","year":"2009","journal-title":"European Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2012.02.031_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/YIC.0b013e3280119e0c","article-title":"Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation","volume":"22","author":"Gibson","year":"2007","journal-title":"International Clinical Psychopharmacology"},{"issue":"9","key":"10.1016\/j.jad.2012.02.031_bb0160","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2012.02.031_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/schbul\/sbm109","article-title":"Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia","volume":"34","author":"Kumra","year":"2008","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"10.1016\/j.jad.2012.02.031_bb0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/appi.ajp.164.1.173","article-title":"Hyperglycemia in a 7-year-old child treated with aripiprazole","volume":"164","author":"Logue","year":"2007","journal-title":"The American Journal of Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2012.02.031_bb0175","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/01.chi.0000132834.43268.10","article-title":"Aripiprazole and psychotherapy for delusional disorder, erotomanic type","volume":"43","author":"Myers","year":"2004","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2012.02.031_bb0180","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/01.chi.0000183496.44266.bd","article-title":"Priapism associated with oxcarbazepine, aripiprazole, and lithium","volume":"44","author":"Negin","year":"2005","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2012.02.031_bb0185","first-page":"240","article-title":"The use of aripiprazole in early onset schizophrenia: safety and efficacy","volume":"64","author":"Normala","year":"2009","journal-title":"The Medical Journal of Malaysia"},{"key":"10.1016\/j.jad.2012.02.031_bb0190","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.schres.2007.12.103","article-title":"Long-term efficacy and safety of aripiprazole in pediatric patients with bipolar I disorder","volume":"98","author":"Nyilas","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1016\/j.jad.2012.02.031_bb0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.jcp.0000150223.31007.e0","article-title":"Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?","volume":"25","author":"O'Keane","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.02.031_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbq172","article-title":"Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia","author":"Olfson","year":"2011","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"10.1016\/j.jad.2012.02.031_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.WNF.0000240941.13876.5E","article-title":"Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient","volume":"30","author":"Palakurthi","year":"2007","journal-title":"Clinical Neuropharmacology"},{"issue":"9","key":"10.1016\/j.jad.2012.02.031_bb0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00002018-200932040-00006","article-title":"Paediatric atypical Antipsychotic Monitoring Safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings","volume":"32","author":"Rani","year":"2009","journal-title":"Drug Safety"},{"issue":"1","key":"10.1016\/j.jad.2012.02.031_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/cap.2008.0163","article-title":"Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post hoc analysis of randomized clinical trial data","volume":"20","author":"Robb","year":"2010","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"7","key":"10.1016\/j.jad.2012.02.031_bb0220","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/08830738050200071301","article-title":"Aripiprazole in children and adolescents: clinical experience","volume":"20","author":"Rugino","year":"2005","journal-title":"Journal of Child Neurology"},{"issue":"3","key":"10.1016\/j.jad.2012.02.031_bb0225","first-page":"42","article-title":"Normalization of risperidone-induced hyperprolactinemia with the addition of aripiprazole","volume":"2","author":"Shores","year":"2005","journal-title":"Psychiatry (Edgmont)"},{"issue":"3","key":"10.1016\/j.jad.2012.02.031_bb0230","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/chi.0b013e31802ed925","article-title":"Acute dystonia associated with aripiprazole in a child","volume":"46","author":"Singh","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.jad.2012.02.031_bb0235","series-title":"AACAP New Research Poster Presentation 3.56","article-title":"Weight gain in Illinois foster children treated with second generation antipsychotics","author":"Singh","year":"2010"},{"issue":"5","key":"10.1016\/j.jad.2012.02.031_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/cap.2007.0036","article-title":"Successful treatment of catatonia with aripiprazole in an adolescent with psychosis","volume":"17","author":"Strawn","year":"2007","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jad.2012.02.031_bb0245","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/17410541.5.4.361","article-title":"Pharmacogenetic testing of CYP2D6 in patients with aripiprazole-related extrapyramidal symptoms: a case\u2013control study","volume":"5","author":"Subuh Surja","year":"2008","journal-title":"Personalized Medicine"},{"issue":"10","key":"10.1016\/j.jad.2012.02.031_bb0250","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1017\/S1092852900015443","article-title":"Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: an open clinical trial","volume":"12","author":"Tramontina","year":"2007","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.jad.2012.02.031_bb0255","doi-asserted-by":"crossref","first-page":"s96","DOI":"10.1192\/bjp.191.51.s96","article-title":"Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study","volume":"191","author":"Woods","year":"2007","journal-title":"The British Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2012.02.031_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/pn.45.3.psychnews_45_3_001","article-title":"More antipsychotics approved for pediatric use","volume":"45","author":"Yan","year":"2010","journal-title":"Psychiatric News"},{"issue":"3","key":"10.1016\/j.jad.2012.02.031_bb0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disorders"},{"issue":"1","key":"10.1016\/j.jad.2012.02.031_bb0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1586\/14737175.4.1.53","article-title":"Pharmacologic treatment of adolescent and child schizophrenia","volume":"4","author":"Young","year":"2004","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.jad.2012.02.031_bb0275","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.euroneuro.2011.04.001","article-title":"Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies","volume":"21","author":"Zuddas","year":"2011","journal-title":"European Neuropsychopharmacology"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712001450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712001450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T03:24:53Z","timestamp":1561433093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032712001450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":55,"alternative-id":["S0165032712001450"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.02.031","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}